Compare

Milestone Pharmaceuticals Inc. vs Korro Bio, Inc. vs PMV Pharmaceuticals, Inc. vs Aardvark Therapeutics, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearMilestone Pharmaceuticals Inc.
MIST
Korro Bio, Inc.
KRRO
PMV Pharmaceuticals, Inc.
PMVP
Aardvark Therapeutics, Inc.
AARD
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenuen/a$6.39Mn/a$0
Revenue growth (YoY)n/a+181.5%n/an/a
Gross marginn/an/an/an/a
Operating marginn/an/mn/an/a
Net marginn/an/mn/an/a
Net income-$63.06M-$117.26M-$77.74M-$57.59M
EPS (Diluted)-$0.75-$12.48-$1.48-$2.93
Operating cash flow-$49.04M-$78.56M-$73.58M-$54.17M
Free cash flow-$49.34M-$79.08M-$73.61M-$54.27M
Cash & equivalents$73.05M$21.82M$37.98M$47.05M
Total assets$113.56M$113.51M$116.56M$117.18M
Total liabilities$71.79M$62.07M$11.85M$10.55M
Shareholders' equity$41.77M$51.44M$104.71M$106.63M
Return on year-end equity-151.0%-228.0%-74.2%-54.0%
Shares outstanding106.24M9.42M53.33M21.82M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearMilestone Pharmaceuticals Inc.Korro Bio, Inc.PMV Pharmaceuticals, Inc.Aardvark Therapeutics, Inc.
Latestn/a$6.39M
Ended 2025-12-31
n/a$0
Ended 2025-12-31
1 year earliern/a$2.27M
Ended 2024-12-31
n/an/a
2 years earliern/a$0
Ended 2023-12-31
n/an/a
3 years earliern/an/an/an/a
4 years earliern/an/an/an/a